The interest in the healthcare industry for flexible instruments is growing fast. By 2033, GlobalData anticipates the minimally invasive devices market to reach $3.1bn, which would represent an estimated 50% growth from today’s levels. F
Flexible instruments are used to guide, position, catch, cut or grasp in the narrow pathways in the body. This treatment approach is expanding to more indications in cardiac disease and in fields such as neurology, oncology, and urology.
In Episode six of the Advancing the Future of Medtech with Alleima podcast series, Tom Schmid, Global Product Manager for flexible instruments at Alleima’s medical unit talks through the market trends in minimally invasive treatment, what they mean for the value chain, and how Alleima, a world-leading engineering company headquartered in Sandviken, Sweden, is innovating so that these procedures can treat even more diseases for the best possible patient outcome.
Listen below:
Alleima specialises in advanced metallurgy and state-of-the-art medical wire manufacturing technologies and has more than 25 years’ of experience in processing nitinol.
By combining its nitinol processing expertise with its longstanding experience of manufacturing ultra-fine sensing, stimulation and transmitting wires, it is uniquely positioned to provide the next generation of smaller and smarter flexible instruments.
To hear more, listen to the first podcast in a series of two with Tom.
Stay tuned for the next episode on flexible instruments and an innovation developed by Alleima that targets the duodenum mucosa layer which could offer sufferers of type-2 diabetes and other metabolic disorders a new form of treatment.
Catch up on earlier episodes below:
